ES476473A1 - Procedimiento para la preparacion de acidos acilhidrocarbi- laminoalcanoicos - Google Patents

Procedimiento para la preparacion de acidos acilhidrocarbi- laminoalcanoicos

Info

Publication number
ES476473A1
ES476473A1 ES476473A ES476473A ES476473A1 ES 476473 A1 ES476473 A1 ES 476473A1 ES 476473 A ES476473 A ES 476473A ES 476473 A ES476473 A ES 476473A ES 476473 A1 ES476473 A1 ES 476473A1
Authority
ES
Spain
Prior art keywords
optionally substituted
substituted phenyl
pharmaceutical compositions
acylhydrocarbylaminoalcanecarboxylic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476473A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of ES476473A1 publication Critical patent/ES476473A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la preparación de los ácidos acilhidrocarbilaminoalcanoicos de la fórmula general I **fórmula** , en donde R1 significa un radical hidrocarbonado alifático o alicíclico o un grupo fenilo eventualmente sustituído, R2 significa un átomo de hidrógeno, un grupo alcohilo, un grupo alquenilo o un grupo alquinilo, R3 significa un átomo de hidrógeno, un grupo alcohilo, un grupo cicloalcohilo o un radical fenilo eventualmente sustituído, R4 significa un grupo alcohilo, un grupo cicloalcohilo, un grupo fenilo eventualmente sustituído siendo al menos 3 la suma de de los átomos de carbono de los sustituyents alcohilo R2, R3 y R4, ó R3 y R4 significan en común un grupo alcohileno o R2, R3 y R4 con inclusión del átomo de carbono contiguo significan un radical adamantilo, n significa 3, 4 ó 5, así como sus sales con bases orgánicas o inorgánicas, caracterizado porque se acila un ácido hidrocarbilaminoalcanoico de la fórmula general II **fórmula** en donde R2, R3 R4 y n tienen los significados precedentemente indicados, eventualmente con protección del grupo carboxilo, con un derivado¿acílico de la fórmula general III R1-CO-R8 (III), en donde R8 significa un grupo sobrante activo o un grupo R1-CO-O y R1 tiene los significados arriba mencionados y eventualmente a continuación se transforma en las sales ; se hidrogena un ácido hidrocarbilaminoalquenoico de la fórmula general IV **fórmula**, en donde R1 R2, R3 ,R4 y n tienes los significados precedentemente indicados, eventualmente con protección del grupo carboxilo, y eventualmente a continuación se transforma en las sales; o se hace reaccionar un ácido acilaminoalcanoico de la fórmula general V **fórmula**, en donde R1 y n tienen los significados arriba indicados y R9 significa un átomo de hidrógeno o un átomo metálico de un metal alcalino o alcalino-térreo, eventualmente con protección del grupo carboxilo, con un derivado hidrocarbílico de la fórmula general VI **fórmula** en donde R2 , R3 y R4 tienen los significados arriba indicados y R10 representa un grupo sobrante activo, y eventualmente a continuación se transforma en las sales; o se solvoliza un derivado funcional de ácido acilhidrocarbilaminoalcanoico de la fórmula general VII **fórmula** en donde R1, R2, R3 R4 y n tienen los significados arriba indicados y A significa un derivado funcional de un grupo carboxilo, y eventualmente a continuación se transforma en las sales.
ES476473A 1977-12-30 1978-12-29 Procedimiento para la preparacion de acidos acilhidrocarbi- laminoalcanoicos Expired ES476473A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU78805A LU78805A1 (de) 1977-12-30 1977-12-30 Acylhydrocarbylaminoalkansaeuren,ihre herstellung und verwendung sowie sie enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ES476473A1 true ES476473A1 (es) 1979-11-16

Family

ID=19728815

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476473A Expired ES476473A1 (es) 1977-12-30 1978-12-29 Procedimiento para la preparacion de acidos acilhidrocarbi- laminoalcanoicos

Country Status (22)

Country Link
EP (1) EP0002836B1 (es)
JP (1) JPS5498720A (es)
AT (1) AT367396B (es)
AU (1) AU526987B2 (es)
BE (1) BE873259A (es)
CA (1) CA1123433A (es)
DE (2) DE2862077D1 (es)
DK (1) DK588378A (es)
ES (1) ES476473A1 (es)
FR (1) FR2413360A1 (es)
GB (1) GB2012274A (es)
GR (1) GR64162B (es)
HU (1) HU181857B (es)
IL (1) IL56344A0 (es)
IT (1) IT7831447A0 (es)
LU (1) LU78805A1 (es)
NL (1) NL7812644A (es)
NZ (1) NZ189295A (es)
PL (4) PL218178A1 (es)
PT (1) PT69009A (es)
SE (1) SE7813442L (es)
ZA (1) ZA787367B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440941A (en) * 1980-12-22 1984-04-03 Usv Pharmaceutical Corporation Aroyl-aminoacids, amides and esters thereof
DK373383A (da) * 1982-08-20 1984-02-21 Midit Fremgangsmaade til fremstilling af omega-aminosyrederivater
JPS62205095A (ja) * 1986-03-04 1987-09-09 Toyo Jozo Co Ltd 新生理活性物質アルドスタチンおよびその製造法
US6420427B1 (en) * 1997-10-09 2002-07-16 Ono Pharmaceutical Co., Ltd. Aminobutyric acid derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645745A1 (de) * 1967-02-22 1970-12-23 Hoechst Ag Korrosionsschutzmittel fuer fluessige Kohlenwasserstoffe
LU69970A1 (es) * 1974-04-30 1976-03-17

Also Published As

Publication number Publication date
LU78805A1 (de) 1979-07-20
DK588378A (da) 1979-07-01
DE2862077D1 (en) 1982-12-02
DE2856722A1 (de) 1979-07-12
PL212296A1 (es) 1980-01-14
IL56344A0 (en) 1979-03-12
PL218178A1 (es) 1980-05-19
PT69009A (de) 1979-01-01
AU4301078A (en) 1979-07-05
CA1123433A (en) 1982-05-11
GB2012274A (en) 1979-07-25
GR64162B (en) 1980-02-05
EP0002836A1 (de) 1979-07-11
ATA938178A (de) 1981-11-15
AT367396B (de) 1982-06-25
PL218177A1 (es) 1980-05-19
HU181857B (en) 1983-11-28
SE7813442L (sv) 1979-07-01
NL7812644A (nl) 1979-07-03
NZ189295A (en) 1980-11-14
FR2413360A1 (fr) 1979-07-27
PL218176A1 (es) 1980-05-19
EP0002836B1 (de) 1982-10-27
ZA787367B (en) 1979-12-27
AU526987B2 (en) 1983-02-10
BE873259A (fr) 1979-06-29
IT7831447A0 (it) 1978-12-29
JPS5498720A (en) 1979-08-03

Similar Documents

Publication Publication Date Title
EG26287A (en) Fixed solid composition containing pregabalin, glycol or glycerol as moisturizer
GB9900334D0 (en) Tricylic vascular damaging agents
RS49654B (sr) Primena derivata fumarne kiseline
RU96117041A (ru) Применение производных 2-гидрокси-5-фенилазобензойной кислоты в качестве химиопрофилактических и химиотерапевтических агентов при раке ободочной кишки
NO162284C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive spiro(4. (3+n))-2-aza-alkan-3-karboksylsyre-derivater.
NO810479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater
ES488656A1 (es) Procedimiento para la preparacion de derivados de acidos aziridin-2-carboxilicos substituidos en n
ES8202784A1 (es) Un procedimiento para la preparacion de derivados de aminas secundarias.
ES8701228A1 (es) Un metodo para producir una propioxantina
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
EP0328634B1 (en) Pharmaceutical compositions for the treatment of psoriasis
ES476473A1 (es) Procedimiento para la preparacion de acidos acilhidrocarbi- laminoalcanoicos
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ES375067A1 (es) Un metodo para la preparacion de acidos 5 beta-tauroceleni-cos y acidos 5 beta-taurocoladienicos.
DK0581904T3 (da) Fremgangsmåde til inhibering af fibrose
OA08972A (fr) Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leursprocédés de préparation et les compositions pharmaceutiques qui les contiennent
ES472749A1 (es) Procedimiento para la preparacion de derivados de 2hidrazono-propionico
ES355674A1 (es) Metodo de producir amidas basicamente sustituidas de acidosantranilicos n-sustituidos y sales de las mismas.
JPS5673046A (en) Decaprenylamine derivative
JPS5536453A (en) Novel immunosuppressive agent
KR930001906A (ko) 벤즈이미다졸린-2-옥소-1-카복실산 유도체의 용도
ES8606258A1 (es) Procedimiento de preparacion de eteres oximas basicos, y de sus sales de adicion acidas farmaceuticamente aceptables
JPS5536454A (en) Novel immunosuppressive agent
EP0158312A3 (en) 1-cyclohexyl-3,4-dihydroisoquinoline derivatives, process for their preparation and medicament containing them
ES8607968A1 (es) Un derivado de tetrahidro- -carbolina